CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer.
Nie L, Wei Y, Zhang F, Hsu YH, Chan LC, Xia W, Ke B, Zhu C, Deng R, Tang J, Yao J, Chu YY, Zhao X, Han Y, Hou J, Huo L, Ko HW, Lin WC, Yamaguchi H, Hsu JM, Yang Y, Pan DN, Hsu JL, Kleer CG, Davidson NE, Hortobagyi GN, Hung MC.
Nie L, et al. Among authors: tang j.
Nat Commun. 2019 Nov 8;10(1):5114. doi: 10.1038/s41467-019-13105-5.
Nat Commun. 2019.
PMID: 31704972
Free PMC article.